Castle Biosciences wins crucial New York access, but can AdvanceAD-Tx overcome the reimbursement test?
Castle Biosciences gains New York approval for AdvanceAD-Tx, expanding access while reimbursement and clinical adoption remain decisive.
Medical Devices & Diagnostics